Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelli B Pointer

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
JAMA Oncology|May 18, 2023
MGMT Methylation Status in Grades 2 and 3 Gliomas Is Important, but Is It Prognostic?Kelli B Pointer, Na Tosha N Gatson
Trends in Cancer|November 6, 2021
Radiotherapy and immunotherapy: open questions and future strategiesKelli B Pointer, Sean P Pitroda, Ralph R Weichselbaum
Neurosurgery|November 20, 2015
Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic TargetRay R Zhang, Kelli B Pointer, John S Kuo
Neurosurgery|September 18, 2015
New Molecular Insights and Potential Therapies for Diffuse Intrinsic Pontine GliomaRay R Zhang, Kelli B Pointer, John S Kuo
Neurosurgery|July 17, 2015
Oncolytic Herpes Simplex Virus Glioblastoma Therapy is Potentiated by Tumor Necrosis Factor-α InhibitionKelli B Pointer, Ray R Zhang, John S Kuo
Neurosurgery|January 18, 2014
Detecting brain tumor with Raman scattering microscopyKelli B Pointer, Ray R Zhang, John S Kuo, et al.
Neurosurgery|November 20, 2014
Mutational analysis reveals the origin and therapy-driven evolution of recurrent gliomaRay R Zhang, Kelli B Pointer, John S Kuo, et al.
Neurochemistry International|March 25, 2014
Glioblastoma cancer stem cells: Biomarker and therapeutic advancesKelli B Pointer, Paul A Clark, Michael Zorniak, et al.
Journal of Applied Clinical Medical Physics|February 24, 2021
Radiation treatment planning study to investigate feasibility of delivering Immunotherapy in Combination with Ablative Radiosurgery to Ultra-High DoSes (ICARUS)Michelle B Rokni, Kelli B Pointer, Jonathan George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2016
Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma PatientsKelli B Pointer, Paul A Clark, Kevin W Eliceiri, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
JAMA Oncology|May 18, 2023
MGMT Methylation Status in Grades 2 and 3 Gliomas Is Important, but Is It Prognostic?Kelli B Pointer, Na Tosha N Gatson
Trends in Cancer|November 6, 2021
Radiotherapy and immunotherapy: open questions and future strategiesKelli B Pointer, Sean P Pitroda, Ralph R Weichselbaum
Neurosurgery|November 20, 2015
Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic TargetRay R Zhang, Kelli B Pointer, John S Kuo
Neurosurgery|September 18, 2015
New Molecular Insights and Potential Therapies for Diffuse Intrinsic Pontine GliomaRay R Zhang, Kelli B Pointer, John S Kuo
Neurosurgery|July 17, 2015
Oncolytic Herpes Simplex Virus Glioblastoma Therapy is Potentiated by Tumor Necrosis Factor-α InhibitionKelli B Pointer, Ray R Zhang, John S Kuo
Neurosurgery|January 18, 2014
Detecting brain tumor with Raman scattering microscopyKelli B Pointer, Ray R Zhang, John S Kuo, et al.
Neurosurgery|November 20, 2014
Mutational analysis reveals the origin and therapy-driven evolution of recurrent gliomaRay R Zhang, Kelli B Pointer, John S Kuo, et al.
Neurochemistry International|March 25, 2014
Glioblastoma cancer stem cells: Biomarker and therapeutic advancesKelli B Pointer, Paul A Clark, Michael Zorniak, et al.
Journal of Applied Clinical Medical Physics|February 24, 2021
Radiation treatment planning study to investigate feasibility of delivering Immunotherapy in Combination with Ablative Radiosurgery to Ultra-High DoSes (ICARUS)Michelle B Rokni, Kelli B Pointer, Jonathan George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2016
Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma PatientsKelli B Pointer, Paul A Clark, Kevin W Eliceiri, et al.
Pageof 3